Free Courses Sale ends Soon, Get It Now


COVAXIN          

5th November, 2021

 

Disclaimer: Copyright infringement not intended.

 

Context

  • Covaxin gets WHO’s emergency use no.

 

About

  • According to WHO, Covaxin has 78% efficacy against COVID-19 of any severity, 14 or more days after the second dose, and is extremely suitable for low- and middle-income countries due to its easy storage requirements.
  • Covaxin vaccine was reviewed by the WHO’s Strategic Advisory Group of Experts on Immunization (SAGE).

 

 

Significance

  • Validation by the WHO is a very significant step towards ensuring global access to India’s widely administered, safe and efficacious Covaxin.

 

https://epaper.thehindu.com/Home/ShareArticle?OrgId=GGH95F3RG.1&imageview=0